Literature DB >> 26594588

Crystal structure of 2-(4-methyl-piperazin-1-yl)quinoline-3-carbaldehyde.

R Nivedita Desai1, S Sreenivasa1, S Naveen2, N K Lokanath3, P A Suchetan1, D B Aruna Kumar1.   

Abstract

In the title compound, C15H17N3O, the aldehyde group is twisted relative to the quinoline group by17.6 (2)° due to the presence of a bulky piperazinyl group in the ortho position. The piperazine N atom attached to the aromatic ring is sp (3)-hybridized and the dihedral angle between the mean planes through the the six piperazine ring atoms and through the quinoline ring system is 40.59 (7)°. Both piperazine substituents are in equatorial positions.

Entities:  

Keywords:  crystal structure; piperazines; quinolines

Year:  2015        PMID: 26594588      PMCID: PMC4645024          DOI: 10.1107/S2056989015020186

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

For biological activity of quinoline derivatives, see: Nasveld et al. (2005 ▸); Eswaran et al. (2009 ▸); Leatham et al. (1983 ▸); Muruganantham et al. (2004 ▸); Maguire et al. (1994 ▸); Wilson et al. (1992 ▸); Strekowski et al. (1991 ▸). For photonic and electronic properties of poly-substituted quinolines, see: Gyoten et al. (2003 ▸).

Experimental

Crystal data

C15H17N3O M = 255.32 Monoclinic, a = 12.3282 (4) Å b = 5.8935 (2) Å c = 18.9202 (7) Å β = 103.591 (2)° V = 1336.18 (8) Å3 Z = 4 Cu Kα radiation μ = 0.65 mm−1 T = 296 K 0.28 × 0.26 × 0.24 mm

Data collection

Bruker APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▸) T min = 0.838, T max = 0.859 9762 measured reflections 2181 independent reflections 1859 reflections with I > 2σ(I) R int = 0.048

Refinement

R[F 2 > 2σ(F 2)] = 0.054 wR(F 2) = 0.162 S = 1.06 2181 reflections 173 parameters H-atom parameters constrained Δρmax = 0.22 e Å−3 Δρmin = −0.24 e Å−3

Data collection: APEX2 (Bruker, 2009 ▸); cell refinement: APEX2 and SAINT-Plus (Bruker, 2009 ▸); data reduction: SAINT-Plus and XPREP (Bruker, 2009 ▸); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▸); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▸); molecular graphics: Mercury (Macrae et al., 2008 ▸); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015020186/gk2647sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015020186/gk2647Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015020186/gk2647Isup3.cml Click here for additional data file. . DOI: 10.1107/S2056989015020186/gk2647fig1.tif Mol­ecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level. CCDC reference: 1433198 Additional supporting information: crystallographic information; 3D view; checkCIF report
C15H17N3OPrism
Mr = 255.32Dx = 1.269 Mg m3
Monoclinic, P21/nMelting point: 384 K
Hall symbol: -P 2ynCu Kα radiation, λ = 1.54178 Å
a = 12.3282 (4) ÅCell parameters from 143 reflections
b = 5.8935 (2) Åθ = 3.9–64.5°
c = 18.9202 (7) ŵ = 0.65 mm1
β = 103.591 (2)°T = 296 K
V = 1336.18 (8) Å3Prism, colourless
Z = 40.28 × 0.26 × 0.24 mm
F(000) = 544
Bruker APEXII CCD diffractometer2181 independent reflections
Radiation source: fine-focus sealed tube1859 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.048
phi and φ scansθmax = 64.5°, θmin = 3.9°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −14→14
Tmin = 0.838, Tmax = 0.859k = −6→6
9762 measured reflectionsl = −21→21
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.054Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.162H-atom parameters constrained
S = 1.06w = 1/[σ2(Fo2) + (0.1151P)2 + 0.0654P] where P = (Fo2 + 2Fc2)/3
2181 reflections(Δ/σ)max < 0.001
173 parametersΔρmax = 0.22 e Å3
0 restraintsΔρmin = −0.24 e Å3
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
N10.44347 (10)0.7887 (2)0.60405 (6)0.0446 (4)
N20.31637 (10)0.4894 (2)0.58318 (6)0.0443 (4)
N30.15374 (11)0.2821 (2)0.46867 (7)0.0492 (4)
O10.33529 (13)0.4038 (3)0.79890 (7)0.0800 (5)
C10.38623 (12)0.6362 (3)0.63074 (7)0.0415 (4)
C20.39605 (12)0.6082 (3)0.70773 (8)0.0435 (4)
C30.46317 (13)0.7537 (3)0.75426 (8)0.0456 (4)
H30.46900.74100.80400.055*
C40.52382 (12)0.9229 (3)0.72789 (8)0.0429 (4)
C50.59503 (14)1.0786 (3)0.77313 (9)0.0517 (5)
H50.60351.07180.82320.062*
C60.65119 (15)1.2380 (3)0.74416 (10)0.0571 (5)
H60.69801.33970.77440.068*
C70.63874 (16)1.2497 (3)0.66853 (10)0.0580 (5)
H70.67681.36060.64900.070*
C80.57153 (14)1.1003 (3)0.62334 (9)0.0516 (5)
H80.56481.10940.57340.062*
C90.51232 (12)0.9326 (3)0.65156 (8)0.0430 (4)
C100.19665 (13)0.5037 (3)0.58101 (8)0.0477 (4)
H10A0.16590.64130.55600.057*
H10B0.18610.51000.63020.057*
C110.13648 (13)0.3007 (3)0.54226 (9)0.0517 (5)
H11A0.16350.16420.56940.062*
H11B0.05730.31420.53990.062*
C120.27299 (14)0.2697 (3)0.47221 (9)0.0522 (5)
H12A0.28460.25820.42340.063*
H12B0.30380.13470.49880.063*
C130.33266 (14)0.4768 (3)0.50926 (8)0.0516 (5)
H13A0.41170.46700.51060.062*
H13B0.30310.61230.48240.062*
C140.09682 (18)0.0831 (4)0.43236 (9)0.0660 (6)
H14A0.11060.07080.38460.099*
H14B0.01810.09730.42850.099*
H14C0.1242−0.05010.46000.099*
C150.34545 (14)0.4132 (3)0.73732 (9)0.0561 (5)
H150.32010.29130.70670.067*
U11U22U33U12U13U23
N10.0470 (7)0.0482 (8)0.0386 (7)−0.0039 (6)0.0102 (6)0.0002 (5)
N20.0423 (7)0.0538 (9)0.0381 (7)−0.0054 (6)0.0119 (5)−0.0038 (6)
N30.0541 (8)0.0505 (9)0.0400 (7)−0.0114 (6)0.0047 (6)0.0021 (6)
O10.0885 (10)0.1024 (13)0.0487 (8)−0.0299 (8)0.0151 (7)0.0178 (7)
C10.0400 (8)0.0462 (9)0.0389 (8)0.0020 (6)0.0102 (6)0.0015 (6)
C20.0408 (8)0.0503 (10)0.0392 (8)0.0025 (6)0.0088 (6)0.0038 (7)
C30.0456 (9)0.0556 (10)0.0348 (8)0.0055 (7)0.0076 (6)0.0042 (7)
C40.0402 (8)0.0467 (9)0.0407 (8)0.0049 (6)0.0077 (6)0.0001 (6)
C50.0529 (10)0.0568 (11)0.0431 (8)0.0002 (8)0.0064 (7)−0.0061 (7)
C60.0583 (10)0.0557 (11)0.0549 (10)−0.0102 (8)0.0086 (8)−0.0100 (8)
C70.0640 (11)0.0530 (11)0.0576 (10)−0.0139 (8)0.0155 (8)−0.0007 (8)
C80.0574 (10)0.0544 (11)0.0439 (8)−0.0055 (8)0.0142 (7)0.0014 (7)
C90.0427 (8)0.0458 (10)0.0402 (8)0.0020 (6)0.0090 (6)−0.0002 (6)
C100.0450 (9)0.0568 (11)0.0420 (8)−0.0011 (7)0.0117 (6)0.0002 (7)
C110.0481 (9)0.0603 (11)0.0465 (9)−0.0097 (7)0.0108 (7)0.0025 (7)
C120.0614 (10)0.0561 (11)0.0402 (8)−0.0041 (7)0.0143 (7)−0.0042 (7)
C130.0513 (9)0.0644 (11)0.0424 (8)−0.0112 (8)0.0180 (7)−0.0056 (7)
C140.0820 (13)0.0605 (12)0.0491 (10)−0.0239 (9)0.0026 (9)0.0008 (8)
C150.0567 (10)0.0634 (12)0.0449 (9)−0.0096 (8)0.0050 (7)0.0107 (8)
N1—C11.315 (2)C6—H60.9300
N1—C91.375 (2)C7—C81.364 (3)
N2—C11.391 (2)C7—H70.9300
N2—C131.4607 (18)C8—C91.406 (2)
N2—C101.4693 (19)C8—H80.9300
N3—C141.454 (2)C10—C111.505 (2)
N3—C121.458 (2)C10—H10A0.9700
N3—C111.461 (2)C10—H10B0.9700
O1—C151.202 (2)C11—H11A0.9700
C1—C21.442 (2)C11—H11B0.9700
C2—C31.361 (2)C12—C131.510 (2)
C2—C151.479 (2)C12—H12A0.9700
C3—C41.406 (2)C12—H12B0.9700
C3—H30.9300C13—H13A0.9700
C4—C51.411 (2)C13—H13B0.9700
C4—C91.419 (2)C14—H14A0.9600
C5—C61.357 (3)C14—H14B0.9600
C5—H50.9300C14—H14C0.9600
C6—C71.404 (3)C15—H150.9300
C1—N1—C9118.40 (12)N2—C10—C11110.18 (13)
C1—N2—C13116.58 (12)N2—C10—H10A109.6
C1—N2—C10116.60 (12)C11—C10—H10A109.6
C13—N2—C10109.84 (11)N2—C10—H10B109.6
C14—N3—C12110.53 (15)C11—C10—H10B109.6
C14—N3—C11110.40 (13)H10A—C10—H10B108.1
C12—N3—C11109.34 (12)N3—C11—C10111.00 (13)
N1—C1—N2118.89 (12)N3—C11—H11A109.4
N1—C1—C2122.74 (14)C10—C11—H11A109.4
N2—C1—C2118.32 (13)N3—C11—H11B109.4
C3—C2—C1118.36 (14)C10—C11—H11B109.4
C3—C2—C15119.41 (14)H11A—C11—H11B108.0
C1—C2—C15121.90 (15)N3—C12—C13110.89 (14)
C2—C3—C4120.69 (14)N3—C12—H12A109.5
C2—C3—H3119.7C13—C12—H12A109.5
C4—C3—H3119.7N3—C12—H12B109.5
C3—C4—C5123.55 (14)C13—C12—H12B109.5
C3—C4—C9117.08 (14)H12A—C12—H12B108.0
C5—C4—C9119.36 (15)N2—C13—C12108.90 (13)
C6—C5—C4120.59 (15)N2—C13—H13A109.9
C6—C5—H5119.7C12—C13—H13A109.9
C4—C5—H5119.7N2—C13—H13B109.9
C5—C6—C7120.09 (16)C12—C13—H13B109.9
C5—C6—H6120.0H13A—C13—H13B108.3
C7—C6—H6120.0N3—C14—H14A109.5
C8—C7—C6120.80 (16)N3—C14—H14B109.5
C8—C7—H7119.6H14A—C14—H14B109.5
C6—C7—H7119.6N3—C14—H14C109.5
C7—C8—C9120.59 (15)H14A—C14—H14C109.5
C7—C8—H8119.7H14B—C14—H14C109.5
C9—C8—H8119.7O1—C15—C2123.51 (18)
N1—C9—C8118.78 (13)O1—C15—H15118.2
N1—C9—C4122.64 (14)C2—C15—H15118.2
C8—C9—C4118.56 (15)
  8 in total

1.  Synthesis, anticonvulsant and antihypertensive activities of 8-substituted quinoline derivatives.

Authors:  Nithyanantham Muruganantham; Ramaiah Sivakumar; Navaneetharaman Anbalagan; Vedachalam Gunasekaran; Joseph Thomas Leonard
Journal:  Biol Pharm Bull       Date:  2004-10       Impact factor: 2.233

2.  Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents.

Authors:  L Strekowski; J L Mokrosz; V A Honkan; A Czarny; M T Cegla; R L Wydra; S E Patterson; R F Schinazi
Journal:  J Med Chem       Date:  1991-05       Impact factor: 7.446

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  Treatment of acute vivax malaria with tafenoquine.

Authors:  Peter Nasveld; Scott Kitchener
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-01       Impact factor: 2.184

5.  A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives.

Authors:  M P Maguire; K R Sheets; K McVety; A P Spada; A Zilberstein
Journal:  J Med Chem       Date:  1994-07-08       Impact factor: 7.446

6.  Synthesis of eosinophil infiltration inhibitors with antihistaminic activity.

Authors:  Michiyo Gyoten; Hideaki Nagaya; Shigeru Fukuda; Yasuko Ashida; Yasuhiko Kawano
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-02       Impact factor: 1.645

7.  A double blind study of antrafenine, naproxen and placebo in osteoarthrosis.

Authors:  P A Leatham; H A Bird; V Wright; D Seymour; A Gordon
Journal:  Eur J Rheumatol Inflamm       Date:  1983

8.  Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety.

Authors:  Sumesh Eswaran; Airody Vasudeva Adhikari; N Suchetha Shetty
Journal:  Eur J Med Chem       Date:  2009-07-03       Impact factor: 6.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.